Valuation: Becton, Dickinson and Company

Market Cap 49.82B 43.17B 40.74B 36.96B 69.33B 4,775B 69.84B 487B 187B 2,422B 187B 183B 7,701B P/E 2026 *
35.2x
P/E 2027 * 19.6x
Enterprise Value 65.71B 56.94B 53.73B 48.74B 91.44B 6,298B 92.1B 642B 247B 3,195B 247B 241B 10,157B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.24x
Free-Float
73.18%
Yield 2026 *
2.15%
Yield 2027 * 2.18%
1 day+2.85%
1 week-0.99%
Current month-2.76%
1 month-0.27%
3 months+25.08%
6 months+14.78%
Current year-5.75%
1 week 175.2
Extreme 175.2
183.53
1 month 175.2
Extreme 175.2
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
269.52
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Tax

Chief Financial Officer

-190 0.0001%
8/26/26 Sell

Executive/Senior Manager

-165 0.0001%
8/20/26 Tax

Executive/Senior Manager

-1,049 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+2.85%-0.99%-2.10%-30.88% 49.82B
+1.12%-4.84%-22.91%+0.43% 178B
+3.12%-0.39%-0.24%+14.45% 120B
+1.45%-1.43%+7.84%+84.32% 62.25B
-0.45%-4.27%+3.07%+33.55% 48.54B
+1.99%-3.66%+11.10%-16.61% 31.95B
+0.18%-10.93% - - 28.59B
+2.59%+4.48%+40.12%-10.73% 25B
-0.88%-3.61%-11.03%+1.86% 21.59B
+0.41%-2.97%+6.27%-27.24% 20.66B
Average +1.24%-3.35%+3.57%+5.46% 58.68B
Weighted average by Cap. +1.55%-3.25%-4.18%+10.44%

Financials

2026 *2027 *
Net sales 19.26B 16.69B 15.75B 14.29B 26.8B 1,846B 27B 188B 72.48B 936B 72.34B 70.75B 2,977B 19.69B 17.06B 16.1B 14.61B 27.4B 1,887B 27.6B 192B 74.09B 957B 73.95B 72.32B 3,043B
Net income 1.44B 1.24B 1.17B 1.07B 2B 138B 2.01B 14.03B 5.41B 69.85B 5.4B 5.28B 222B 2.34B 2.03B 1.91B 1.74B 3.26B 224B 3.28B 22.85B 8.8B 114B 8.79B 8.59B 362B
Net Debt 15.88B 13.76B 12.99B 11.78B 22.11B 1,522B 22.27B 155B 59.78B 772B 59.66B 58.35B 2,455B 13.95B 12.09B 11.41B 10.35B 19.42B 1,337B 19.56B 136B 52.5B 678B 52.4B 51.25B 2,157B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-09-14 $182.91 +2.85% 1,634,141
26-09-11 $177.85 +0.81% 1,584,103
26-09-10 $176.42 -1.88% 1,705,006
26-09-09 $179.80 +0.39% 1,529,006
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
182.91USD
Average target price
195.67USD
Spread / Average Target
+6.97%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!